Hypercalcemia Treatment Market Will Grow at Highest Pace Owing to Biotech Advances

The growing Hypercalcemia Treatment Market Growth is fueled by an aging global population, rising prevalence of chronic kidney disease, and increasing incidence of malignancy‐related calcium dysregulation. As life expectancy increases, more patients present with secondary hyperparathyroidism, necessitating long term management strategies.
Hypercalcemia treatment encompasses a range of pharmaceutical agents and therapeutic protocols designed to restore calcium homeostasis in patients presenting elevated serum calcium levels. Products include calcimimetics such as cinacalcet, bisphosphonates, monoclonal antibodies targeting parathyroid hormone and emerging gene‐based therapies.

Hypercalcemia Treatment Market

https://www.coherentmarket...

#HypercalcemiaTreatment ,#BiopharmaInnovation,#ChronicDiseaseCare,#AsiaPacificHealthcare,#CoherentmarketInsights.